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IVUS-guided group (p0.029), resulting in significant difference in ST-elevation MI
between two groups (9.8% vs. 2.4%, p0.030).
Conclusions: IVUS-guided two-stent techniques was associated with significantly
reduced late stent thrombosis, with resultant reduction of ST-elevation myocardial
infarction.
Table 7. Clinical follow-up after propensity score matching
IVUS-guided
(n123)
Angio-guided
(n123) p
In-hospital, n (%)
Stent thrombosis 2(0.6) 5(1.6) 0.272
Overall death 1(0.3) 3(1.0) 0.359
Cardiac 1(0.3) 3(1.0) 0.359
Myocardial infarction 12(3.7) 11(3.6) 1.000
STEMI 3(0.9) 6(2.0) 0.327
CABG 0 0 NS
TLR 0 1(0.3) 0.484
TVR 0 1(0.3) 0.484
MACE 12(3.7) 11(3.6) 1.000
Procedural success, n (%) 312(96.3) 293(96.4) 1.000
At 12-month
Stent thrombosis 1(0.8) 10(8.1) 0.010
definite 1(0.8) 9(7.3) 0.019
probable 0 1(0.8) 1.000
possible 0 0 NS
early 1(0.8) 4(3.3) 0.370
late 0 6(4.9) 0.029
Overall death 0 5(4.1) 0.060
Cardiac 0 4(3.3) 0.122
Myocardial infarction 4(3.3) 12(9.8) 0.067
STEMI 3(2.4) 12(9.8) 0.030
CABG 0 1(0.8) 1.000
TLR 13(10.6) 11(11.4) 1.000
TVR 14(11.4) 17(13.8) 0.701
MACE 20(16.3) 22(17.9) 0.866
IVUS, intravascular ultrasound; STEMI, ST-segment elevation myocardial
infarction; CABG, coronary artery bypass graft; TLR, target lesion
revascularization; TVR, target vessel revascularization; MACE, major adverse
cardiac event
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Background: Emerging data suggest that 2nd generation drug-eluting stents (DES) may
improve event-free survival compared to 1st generation DES. Whether or not this applies
to both sexes is unknown.
Methods: The SPIRIT II, III and IV randomized controlled trials (RCT) compared the
second-generation everolimus-eluting stent (EES) to the first-generation paclitaxel-eluting
stent (PES). Summary-level data of each study was pooled using meta-analytic tech-
niques. We evaluated the impact of gender on adverse events stratified by DES type.
Relative risks and 95% confidence intervals were calculated for the following outcomes:
definite or probable stent thrombosis (ST), target lesion revascularization (TLR), myo-
cardial infarction (MI), major adverse cardiovascular events (MACE) and cardiac death.
Results: Women (n1583, 31.7%), were older, more often diabetic and less likely to
have multivessel disease compared to men. After a weighted mean follow-up of 2.3 years,
among patients receiving PES, the incidence of MACE was significantly higher while
rates of MI and TLR were modestly higher among women (Figure). In contrast, MACE
rates were lower with EES than PES in both men and women, and outcomes were similar
in men and women receiving EES. Rates of ST (0.5% vs. 0.7%, p0.65) and cardiac
death (0.9% vs. 1.0%, p0.95) in EES-treated patients did not differ in women vs. men.
Conclusions: In this pooled analysis of RCT, adverse events were modestly higher among
women compared to men treated with PES. In contrast, outcomes were improved with EES
in both men and women such that female sex was no longer associated greater MACE.
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Background: Quantitative evaluation of collateral flow by coronary computed tomog-
raphy angiography (CCTA) has not been reported. We did a proof-of-concept study to
determine the extent or direction of CCTA.
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Methods: From 105 patients (male gender 79%, age 61.611.0 years), the
angiographic grade and direction of collateral flow in 121 totally occluded vessels
was compared to the transluminal attenuation gradient of vessel distal to total
occlusion (TAGdistal) derived from 64-detector row CCTA. TAG is defined as the
linear gradient of luminal attenuation along coronary artery, and was validated
against angiographical stenosis and flow velocity in our previous study.
Results: TAGdistal increased consistently and significantly with the degree of
collateral flow, from -4.434.02 HU/mm for Rentrop score 0 to 0.821.08
HU/mm for Rentrop score 3 (p0.0001). TAGdistal was also significantly higher
in retrograde flow compared to anterograde collateral flow (-2.443.04 HU/mm
versus 1.332.59 HU/mm, p0.0001). The well-developed collateral vessel that
have Rentrop score 2 or 3, which was found in 42.1% (51/121), could be predicted
by the TAGdistal cutoff value of  -1.28 HU/mm with area under receiver
operating characteristic curve of 0.689, and with a sensitivity and specificity,
positive and negative predictive value of 86.3%, 47.1%, and 54.3%, 82.5%,
respectively.
Conclusions: As far as we know, this is the first study showing that CT can
evaluate coronary collateral flow. Using TAG method, CCTA appears to be able
to measure quantitatively the degree and direction of coronary collateral circula-
tion, and predict angiographically well developed collateral vessels. These
abilities of CCTA may be useful for evaluation of patients with complex coronary
artery disease.
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Background: Coronary CT angiography (CCTA) has been used to predict procedural
success of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO).
However, the role of CCTA on the procedural outcome has not been reported in a
large-scaled study. We investigated the impact of pre-procedural CCTA on the procedural
success of CTO PCI on a patient-basis.
Methods: We retrospectively compared 2,840 patients without pre-procedural CCTA (no
CCTA group) and 658 patients with CCTA (CCTA group) from e-CTO, a Korean
multicenter registry comprising 26 centers. Results were further confirmed in propensity-
matched subgroup (N1,316).
Results: CCTA groups were younger (62.110.6 vs. 63.111.2), more were
female (21.9% vs. 27.4%), more had CTO in right coronary artery (45.0% vs.
37.6%, p0.05), and more risk factors. These differences were eliminated after
matching of 21 variables. The unadjusted CTO PCI success rate was lower in
CCTA group compared to non CCTA group (83.4% vs. 75.2%), and it was
consistent in subgroup analyses by lesion location (LAD, 78.4% vs. 85.7%; LCX,
72.5% vs. 84.3%; RCA, 73.3% vs. 80.4%, p0.05). The use of pre-procedural
CCTA was related to 0.61-fold decrease of odds for procedural success (95%
confidence interval (CI)0.49-0.74, p0.001) in unadjusted model. This result
was confirmed in covariate-adjusted model (OR0.57, 95% CI0.45 – 0.71) and
in propensity-score matched model (OR0.61, 95% CI0.47 – 0.80, p0.001).
Conclusions: Pre-procedural CCTA did not show beneficial impact on the procedural
success of CTO PCI in our multicenter registry. Careful selection or sophisticated CCTA
analytic methods would be required to demonstrate the clinical role of pre-procedural CCTA
before CTO PCI.
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Background: Chronic total occlusions (CTO) are the final stage of coronary
atherosclerosis. Coronary arteries with CTO have shown large plaque burden and
negative remodeling of the occluded region and the segments located distal to the
occlusion. Lumen and plaque changes located distal to successfully re-canalized
CTO remain unknown at follow-up.
Methods: Ninety-one CTO successfully treated with drug-eluting stents in 86
patients underwent quantitative angiography at baseline and 12-18 months
follow-up. Thirty-one lesions were investigated with IVUS. All analyses were
performed after nitroglycerin. Angiographic changes of were assessed with
quantitative coronary angiography as differences in minimal, mean and maximal
lumen diameter (MinLD, MeanLD and MaxLD, respectively). Vessel remodeling
was assessed with IVUS as changes in lumen, plaque and vessel volume.
Results: At follow-up, MinLD increased 23.9% (from 0.880.32 to 1.090.35mm:
p0.01), MeanLD 16.4% (from 1.590.44 to 1.850.45mm; p0.01) and MaxLD
11.7% (from 2.390.67 to 2.670.70mm; p0.01). Lumen enlargement was greater in
non-restenotic lesions, small lumen area at baseline and low LDL-cholesterol levels
during the study period. By IVUS, lumen increased 26.9% (from 108.189.2 to
137.3115.3mm3; p0.01), vessel increased 12.1% (from 207.1170.2 to 232.2196.0
mm3; p0.01) and plaque tended to decrease (-3.9%, from 98.988.7 to 94.989.3
mm3; p0.07). Small lumen at baseline was related to greater lumen enlargement.
Conclusions: Distal segments to re-canalized CTO show a notable lumen and
vessel enlargement with a trend towards of mild plaque regression. Low
LDL-Cholesterol levels during the study increases lumen enlargement. Angio-
graphic lesions distal to CTO may change and stent implantation must be
discouraged.
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Background: Introduction The J-CTO score has been shown to predict successful
guidewire crossing within 30 minutes in percutaneous coronary intervention (PCI)
for chronic total occlusions (CTO) in a multicentre Japanese registry. Hypothesis
We assessed the hypothesis that the J-CTO score is a useful risk score for
the prediction of procedural failure of PCI for CTO in a different cohort of
patients.
Methods: Methods The study included all consecutive patients undergoing PCI
for CTO at 3 tertiary PCI centres between January 2004 and December 2011. The
J-CTO score assigns 1 point to each of the following: calcification, bending, blunt
stump, occlusion length 20 mm, and previously failed lesion and classifies
lesions as easy (score of 0), intermediate (score of 1), difficult (score of 2), and
“very difficult” (score of 3). A multivariable mixed effect logistic regression for
clustered data was used to assess the impact of J-CTO score on PCI failure. Model
calibration was assessed as difference between predicted probabilities with the
worst or best prognosis (PSEP). Areas under receiver-operating characteristic
curve (AUC) were computed.
Results: Results A total of 1261 patients, median age 63 yrs-old (25th-75th
percentile, 55-72), undergoing PCI for 1418 CTO were included. PCI failure
occurred in 410 (28.9%) lesions. Failure rate significantly increased with
increasing J-CTO score (13.6%, 24.7%, 37.0%, 44.8%, in the groups with J-CTO
score of 0, 1, 2, 3, respectively, p0.001). At multivariable logistic regression
J-CTO score was a significant predictor of failure (odds ratio 1.68, 95%
confidence interval (CI) 1.43-1.97, p0.001, for each unit increase in J-CTO
score). PSEP was 0.34 and 0.33 in a model containing J-CTO score only, or
containing J-CTO score in addition to clinical, procedural variables and vessel
site, respectively. The AUC of a model containing J-CTO score only was
significantly higher than AUC of a model containing J-CTO score in addition to
clinical, procedural variables and vessel site (0.77, 95% CI 0.75-0.80, vs. 0.71,
95% CI 0.69- 0.74, p0.001).
Conclusions: Conclusions The J-CTO score is an independent predictor of failure of PCI
for CTO and has a good predictive accuracy as stand-
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Background: Septal channel perforation occurs rarely in retrograde recanalization
via septal channel for chronic total occlusion (CTO) lesions. There has been little
data on mid-term angiographic outcomes of septal channel perforation.
Methods: Septal channel perforation with cardiac tamponade or spreading
myocardial blush was treated with coil or fat tissue to occlude, balloon dilatation
at the donor artery, and administration of protamine. Persistent septal channel
perforation into the ventricle and coronary sinus or of non-growing myocardial
blush was followed up by no treatment. We examined the angiographic outcome
of no treatment cases of septal channel perforation.
Results: Between October 2005 and December 2011, we performed the retrograde
approach in 465 patients with 484 CTO lesions. Of these, the septal channel was
used in 55.2% (267/484), and its in-hospital outcomes were no major adverse
cardiac events and 1 cardiac tamponade. The incidence of septal channel
perforation was 15.4% (41/267). In septal channel perforation cases, we used the
coil (n5), fat tissue (n2), balloon dilatation (n3), and protamine (n15). Of
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